Our sister company Quay Pharmaceuticals Limited provides a comprehensive outsourcing service for the development and testing of pharmaceutical products, including the manufacture of clinical trial supplies.

Quay holds a Manufacturing Authorisation from the MHRA for the manufacture and testing of investigational medicinal products (IMP's), as specified by the EU Clinical Trial Directive (2001/20/EC).

They also hold a manufacturing licence for specials and are well equipped with both laboratory, processing and testing equipment, as well as pilot scale machinery up to 50kg.

With access to the most advanced analytical instrumental techniques, the company is able to undertake almost any analytical procedure.

Prof. Mike Rubinstein - CEO
The company is headed by Professor Mike Rubinstein, who has over 30 years academic and industrial experience in Pharmaceutical Dosage Form Design, Development and Manufacture. Professor Rubinstein is both a Chemical Engineer and a Pharmacist with QP status and was previously Director of the School of Pharmacy and Chemistry at Liverpool John Moores University in the UK.

Quay Pharma provide the following services:

> Formulation development and optimisation of dosage forms including the design of conventional and controlled release tablets and capsules

> Clinical trial manufacture

> Novel drug delivery design and development

> Analytical R & D

> ICH compliant stability testing

> Analytical method development including validation and transfer

> Process development, scale-up and optimisation

> Drug syntheses

> Solids characterisation

> Compaction simulation

> QA testing & analysis

For more information contact Mike Rubinstein: enquiries@quaypharma.com